Fox Chase Cancer Center Forward, Winter/Spring 2020

Total Page:16

File Type:pdf, Size:1020Kb

Fox Chase Cancer Center Forward, Winter/Spring 2020 BROADENING THE CONVERSATION ABOUT CANCER | WINTER/SPRING 2020 SHATTERING THE GLASS BEAKER Women Past and Present Have Played Key Roles at Fox Chase G43051_Forward Magazine.indb 1 2/25/20 10:16 AM FORWARD THINKING PRESIDENT’S MESSAGE MAKING THE UNCOMMON COMMON or many of us, cancer is Chase a culture and a leader who something familiar. It has helped fuel their drive to contrib- touched us in some way, ute meaningfully to our under- whether personally, in our standing of cancer and to achieve families, or amongst our greatness through their own career Ffriends or colleagues. One might accomplishments. consider it a common thing, but to With the help of new drugs face it takes uncommon strength called immune checkpoint inhib- and exceptional insight. itors, we are seeing success treat- Fox Chase Cancer Center is a ing patients in ways we haven’t be- place where uncommon things fore. In these pages, we share how happen. Within our institution ongoing research is increasing our are people who are extraordi- knowledge of the complexities of nary—patients who carry on the human immune system and boldly through the seemingly im- how to harness its power to kill donors, and the entire Fox Chase possible and clinicians, scientists, cancer. In some cases, the positive family, and we look forward to and sta who do the exceptional to eects of immune checkpoint in- new collaborations on the hori- help them prevail. hibitor drugs last months to years. zon that will help us get closer to Our cover story in this issue There is still much work to do. more breakthroughs. Our story of Forward highlights the role of Right now, only a small number of continues. women in science, particularly patients’ cancers respond to such within our Center. In doing so, drugs, but the results give new it also showcases Fox Chase’s hope for the future. longstanding inclusion of dierent It is an exciting time for us at voices and new ideas in the pursuit Fox Chase. As we have done for of great science and medicine. decades, we continue to ask new These female trailblazers exercised questions, test new ideas, and dis- ingenuity and held close a dedi- cover new ways. We have tremen- Richard I. Fisher, MD cation to discovery, nding at Fox dous support from our patients, PRESIDENT AND CEO EDITORIAL ADVISORY BOARD Joshua E. Meyer, MD Christopher W. McNichol FORWARD magazine is published twice a year for friends of Fox Chase Judith L. Bachman, MSN, RN, CNAA Associate Professor, Donald E. Morel, Jr., PhD Radiation Oncology Leon O. Moulder, Jr. Cancer Center by the communications Forward Chief Operating Officer department of Fox Chase. One of the WINTER/SPRING 2020 Donna L. Skerrett, MD Jennifer Barsky Reese, PhD Ryan O’Neill-Moon leading cancer research and treatment Director of Marketing centers in the United States, Fox Chase Patrick McGee LEADERSHIP Assistant Professor, Cancer Prevention FOUNDATION BOARD was founded in 1904 as one of the Editor and Control Program Amanda Purdy, PhD OF DIRECTORS nation’s first cancer hospitals, and Richard I. Fisher, MD J. Robert Beck, MD Director, Academic Affairs was among the first institutions to be Sarah Hughes President and Donald E. Morel, Jr., PhD Chair designated a National Cancer Institute Chief Academic and Administrative Officer Editorial Assistant Chief Executive Officer Rosalia Viterbo, MD, FACS, Louis E. Della Penna, Sr. Vice Chair Comprehensive Cancer Center in 1974. Associate Professor, William J. Federici Fox Chase joined Temple University Health B&G Design Studios Jeremy Moore George Beschen Senior Director of Individual Giving Department of Surgical Oncology Richard I. Fisher, MD System in 2012. Design Senior Director of Edward A. Glickman Temple Health refers to the health, Brilliant Graphics Communications Richard J. Bleicher, MD, FACS, BOARD OF DIRECTORS Attending Surgeon, Lewis F. Gould Jr. education and research activities carried Printing Patrick McGee Lewis F. Gould, Jr. Chair out by the affiliates of Temple University Breast Cancer Program Leader Thomas W. Hofmann Publications Manager John M. Daly, MD Health System (TUHS) and by The Lewis Fox Chase Barbara Ilsen Katz School Temple University School Cancer Center Inquiries: Lisa Broida Bailey Mary B. Daly, MD, PhD Margot Wallace Keith Director of Donor Relations of Medicine. TUHS neither provides nor Cover [email protected] Ronald R. Donatucci Geoffrey Kent controls the provision of health care. All William J. Federici Contributors: Carolyn Y. Fang, PhD Dan Levin health care is provided by its member Edward A. Glickman organizations or independent health care Jill Horne Coleader, Cancer Prevention Philip E. Lippincott and Control Lon R. Greenberg Solomon C. Luo, MD providers affiliated with TUHS member On the Cover: Chemist Mary Adelia Bennett (left) working in Kimberly D. Hagerich organizations. Each TUHS member Erica A. Golemis, PhD David G. Marshall organization is owned and operated a lab in 1935. Lori Rink (right), an assistant professor in the Thomas W. Hofmann Molecular Therapeutics Program, in her lab in 2019. Deputy Chief Scientific Officer Edward J. Roach pursuant to its governing documents. Larry R. Kaiser, MD Lindy Snider Anne Jadwin, MSN, RN, AOCN, NE-BC Margot Wallace Keith Thomas R. Tritton, PhD Chief Nursing Officer 333 Cottman Avenue, COLIN LENTON Robert H. LeFever Philadelphia, PA 19111-2497 Shawn Kleitz Solomon C. Luo, MD foxchase.org Chief Development Officer David G. Marshall 1-888-FOX-CHASE G43051_Forward Magazine.indb 2 2/25/20 10:16 AM ForwardWINTER/SPRING 2020 CONTENTS FEATURES 6 Shattering the Glass Beaker Women researchers have long played a key role at Fox Chase Cancer Center. As early as 1946, four of 10 laboratory heads were women. To this day, female researchers and physicians who bridge the gap between the laboratory and the clinic have continued to play a vital role. 14 Picking the Lock Cancer can evade the body’s immune system by tricking it into thinking that cancer cells are normal. A newer class of drugs called check- point inhibitors help the immune system overcome this deception and attack cancerous cells. The results have been impressive, but the drugs do not work for all patients. 18 The Unknown Patient When most people hear the words “breast cancer,” they think of women, not men. But even though they are far fewer in number, men do get breast cancer. The men who have struggled with diagnosis and treatment say it can be an 18 isolating experience. DEPARTMENTS 26 MAKING A DIFFERENCE: Feet First to Kick Cancer 2 FOCUS: Around Campus In 2009, a group of friends and sports enthusiasts Fox Chase Nurse Travels to Mozambique for started an annual kickball tournament to fund Volunteer Work | High School Students Create cancer research. Since then, the Kicking Cancer Art to Highlight the Cancer Journey of Patients Foundation has raised $375,000. 22 CLOSE-UP: Patient Perspective: 28 REVIEW: News of Note Faith to Fall Back On Special Events | Honors & Awards | Notable Angela Shammo found out she had breast cancer Accomplishments when she was 40 years old and the mother of four young children. But her faith and excellent 32 REWIND: Hugh Creech: A Fox Chase medical care got her through. Family Story Organic chemist Hugh John Creech came to Fox 24 CLOSE-UP: Faculty Perspective: Chase Cancer Center in 1945 and would go on to A Family of Physicians have a long, distinguished career in pioneering Mariusz Wasik grew up in Poland as the child of work developing and testing chemotherapy drugs. two physicians. He went to medical school, where His wife also worked at Fox Chase as a researcher, he met his wife, who is also a doctor. And one of and his son served as a medical oncologist at the CLINT BLOWERS CLINT his two daughters is a nurse practitioner. center. WINTER/SPRING 2020 FOX CHASE FORWARD 1 G43051_Forward Magazine.indb 3 2/25/20 10:16 AM FOCUS AROUND CAMPUS FOX CHASE NURSE TRAVELS TO MOZAMBIQUE FOR VOLUNTEER WORK lthough based in Philadelphia, Fox Chase Cancer Center has a global reputation, a fact borne out by its many partner- Aships with other cancer centers and researchers around the world. But that global reach also extends to vol- unteer work. Recently, registered nurse Dana Adamson traveled to Mozambique with a group of nurses to provide medical services. They traveled to Macadeira, a small rural community, with a group organized by Nurses for Africa, which is located in the “They were unable to give us anything back, so instead they prayed for us. It was extremely memorable.” — DANA ADAMSON, FOX CHASE REGISTERED NURSE United States but partners with Hands at Work, a local group of mission workers in Africa. The nurses hosted two days of clinics which involved vital signs, assessments, and wound care; people were also prescribed the community.” Fox Chase nurse Dana Adamson with medications by nurses from more On their other days there, some of the children she met on her volunteer trip to Mozambique. developed areas of Mozambique. Adamson said, the nurses did a During those two days they saw day of teaching for both the care over 700 people, Adamson said. workers, who are women in the were able to thank the care workers According to Hands at Work, community that take care of their in the community for their work there is “no shortage of challeng- own family plus other families, by giving them large bags of rice, es” in Macadeira. “Hunger and and the children. They taught two liters of oil, and a bag of salt, starvation are prevalent, as are hand washing, hygiene, nutrition, things that are extremely dicult the risks of HIV/AIDS and malar- wound care, seizure care, and for them to even purchase.
Recommended publications
  • Chestnut Hill College Department of Biology Biomedical Seminar Series
    Chestnut Hill College Department of Biology Biomedical Seminar Series Distinguished Speakers 1994 –2012 BIOmeDIcAL SemINAr SerIeS GOALS AND VISION v To provide a forum at Chestnut Hill College for learning Office of the President recent advances in biomedical research. Since 1994, Chestnut Hill College has been enhanced and broadened by the Biomedical To expose our students and faculty to prominent Seminar Series sponsored by the Biology Department. This series presents students with an v opportunity to meet, interact, listen, and learn from some of the most prestigious scientists in the scientific and medical professionals. country. Over the years, these encounters have opened the doors of research laboratories to our students to provide them with stellar internships and incomparable mentors. It is no exaggeration to say that through these encounters lives have been changed, careers launched, v To foster meaningful interactions and collaboration and horizons expanded. among our neighboring institutions. This program of lectures is genuinely unique; unique because, unlike similar series at large universities, it is neither endowed nor funded by an external source. On the contrary, prominent scientists spend a day of their precious time with Chestnut Hill students out of the To develop new contacts for all our students who are generous bounty of their hearts. Among them are Presidents of institutions, a Nobel Laureate, v Directors of Centers, Senior Administrators, elected members of the National Academy of interested in pursuing careers in biotechnology, basic Sciences, Department Chairpersons, Distinguished Scholars, and Lasker Award recipients. These women and men, who are among the best in their respective fields, exemplify for research, health and medicine.
    [Show full text]
  • 158273436.Pdf
    4. , .;z.. ", ,:,. - 21sk , 44 "00,4 'WM 4 44 44 4 COLD SPRING HARBOR LABORATORY OF QUANTITATIVE BIOLOGY ESTABLISHED JULY 1, 1963 ANNUAL REPORT 1967 COLD SPRING HARBOR, LONG ISLAND, NEW YORK COLD SPRING HARBOR LABORATORY OF QUANTITATIVE BIOLOGY COLD SPRING HARBOR, LONG ISLAND,NEW YORK OFFICERS OF THE CORPORATION Chairman: Dr. H. Bentley Glass Secretary: Dr. Harry G. Albaum 1st Vice-Chairman: Mr. Walter H. Page Treasurer: Mr. Richard B. McAdoo 2nd Vice-Chairman: Assistant Secretary-Treasurer Dr. James D. Watson Mr. John B. Philips Laboratory Director: Dr. John Cairns BOARD OF TRUSTEES AND PARTICIPATING INSTITUTIONS Rockefeller University Albert Einstein College of Medicine Dr. Norton Zinder Dr. Harry Eagle Long Island Biological Association Duke University Mr. Walter H. Page Dr. Samson Gross Princeton University Brooklyn College of the City University of Dr. Arthur B. Pardee New York Dr. Harry G. Albaum New York University Medical Center The Public Health Research Institute of New York University of the City of New York, Inc. Dr. Alan W. Bernheimer Dr. Paul Margolin Sloan-Kettering Institute for Cancer Research Dr. Leo Wade INDIVIDUAL TRUSTEES Dr. H. Bentley Glass Mr. Richard B. McAdoo Dr. I. C. Gunsalus Dr. Lewis Sarett Dr. Alexander Hollaender Mr. Dudley W. Stoddard Dr. James D. Watson TABLE OF CONTENTS Board of Trustees 2 Director's Report 5-7 Year-round Research Activities 8-15 32nd Cold Spring Harbor Symposium "Antibodies" 16-17 Phycomyces Workshop 18-19 Summer Post-Graduate Training Courses 20-22 Undergraduate Research Participation
    [Show full text]
  • 2013 Highlights the Center for Retrovirus Research 2013 Distinguished Research Career Award Dr
    Newsletter of the Center for Retrovirus Research at The Ohio State University College of Veterinary Medicine 2013 Highlights The Center for Retrovirus Research 2013 Distinguished Research Career Award Dr. Anna Marie (Ann) Skalka PhD. Professor and W. W. Smith Chair in Cancer Research, Senior Advisor to the President, Fox Chase Cancer Center, Philadelphia, PA was the 14th recipient of the annual award for her seminal contributions to our understanding of the biochemical mechanisms by which retroviruses (including HIV) replicate and insert their genetic material into the host genome. Dr. Anna Marie Skalka of this protein as well as exploiting it as a therapeutic (center) receives Career target. Dr. Skalka has published more than 240 scientific Award crystal from Center for Retrovirus Research papers and scholarly reviews, has edited several Director Dr. Patrick L. Green scientific books, organized and spoken at national and (right) and Center member international meetings and conferences, and is coauthor Dr. Mamuka Kvaratskhelia of the widely acclaimed textbook, Principles of Virology. (left). Distinguished award lecture entitled Dr. Skalka has served on the editorial boards of several “Deciphering the Anatomy peer-reviewed scientific journals and has been a member of a DNA Invasion Machine: of numerous advisory boards, including the National the Retroviral Integrases”. Cancer Institute Board of Scientific Counselors, the Dr. Skalka obtained her Ph.D. degree in Microbiology General Motors Cancer Research Foundation Awards from New York University Medical School with Dr. Jerard Assembly, the Board of Governors of the American Hurwitz, and was a postdoctoral fellow with Nobel Academy of Microbiology, and the National Advisory Laureate, Dr.
    [Show full text]
  • Celebrating Years
    Chestnut Hill College Department of Biology Celebrating Biomedical Lecture Series 20 Distinguished Speakers Years 1994 – 2013 Keynote Speaker Keynote Speaker 10th Anniversary 20th Anniversary March 2004 September 2013 Stanley B. Prusiner, M.D. Michael S. Brown, M.D. Nobel Prize for Medicine Nobel Prize for Medicine or Physiology or Physiology ii GOALS AND VISION Of the BIOmeDIcAL Lecture SerIeS GOALS AND VISION v To provide a forum at Chestnut Hill College for learning Office of the President recent advances in biomedical research. Since 1994, Chestnut Hill College has been enhanced and broadened by the Biomedical To expose our students and faculty to prominent Seminar Series sponsored by the Biology Department. This series presents students with an v opportunity to meet, interact, listen, and learn from some of the most prestigious scientists in the scientific and medical professionals. country. Over the years, these encounters have opened the doors of research laboratories to our students to provide them with stellar internships and incomparable mentors. It is no exaggeration to say that through these encounters lives have been changed, careers launched, v To foster meaningful interactions and collaboration and horizons expanded. among our neighboring institutions. This program of lectures is genuinely unique; unique because, unlike similar series at large universities, it is neither endowed nor funded by an external source. On the contrary, prominent scientists spend a day of their precious time with Chestnut Hill students out of the To develop new contacts for all our students who are generous bounty of their hearts. Among them are Presidents of institutions, two Nobel v Laureates, Directors of Centers, Senior Administrators, elected members of the National interested in pursuing careers in biotechnology, basic Academy of Sciences, Department Chairpersons, Distinguished Scholars, and Lasker Award recipients.
    [Show full text]
  • Cancer Research 2007.Pdf
    r i a h Dear Governor Corzine: C We who serve on the New Jersey Commission on Cancer Research (NJCCR) thank you most sincerely for your continued support of our activities. This 2007 Annual Report summarizes key accomplishments and e research highlights from a wide range of science supported by our program. h t Throughout this report, you will see evidence of our continued efforts to identify, solicit, and support high quality, innovative research that will have a significant impact on cancer in New Jersey, as well as our commitment to ensure that this research is disseminated and m translated in the health care and public health arenas. o Of greatest significance in 2007 were the exciting results from a 15 month intensive and independent r evaluation of the NJCCR programs that was conducted by members of the Bloustein School of f Urban Policy & Planning at Rutgers, The State University. The NJCCR commissioned this rigorous self-assessment to measure its efficiency and effectiveness based on quantifiable data. It is our pleasure to report that the positive outcomes of NJCCR strategies to promote original and e significant cancer research in New Jersey exceeded our expectations in all categories. g For example, the NJCCR’s open and fair system of Seed Grant awards provides proven benefits to a scientists and research institutions throughout the state by: leveraging $10.44 back to New Jersey for every state dollar spent; stimulating new ideas and research directions and opening doors to national s recognition. Increased funding for state research institutions is also expanded through the indirect costs included in these awards.
    [Show full text]
  • Retroviral Protease (Retroviruses/Avian Sarcoma4eukosis Virus/Human Immunodeficiency Virus) MOSHE KOTLER*T, RICHARD A
    Proc. Natl. Acad. Sci. USA Vol. 85, pp. 4185-4189, June 1988 Biochemistry Synthetic peptides as substrates and inhibitors of a retroviral protease (retroviruses/avian sarcoma4eukosis virus/human immunodeficiency virus) MOSHE KOTLER*t, RICHARD A. KATZ*t, WALEED DANHO§, JONATHAN LEIs¶, AND ANNA MARIE SKALKA*tII *Department of Molecular Oncology, Roche Institute of Molecular Biology and §Peptide Research Department, Hoffmann-La Roche, Inc., Roche Research Center, Nutley, NJ 07110; and $Department of Biochemistry, Case Western Reserve University, Cleveland, OH 44106 Communicated by Sidney Udenfriend, February 16, 1988 ABSTRACT Processing of the gag and pol gene precursor The results presented here show that a decapeptide com- proteins of retroviruses is essential for infectivity and is posed of the cleavage site between the a and pp32 domains directed by a viral protease that is itself included in one ofthese of the ASLV reverse transcriptase-integration polyprotein precursors. We demonstrate here that small synthetic peptides (pol) can be cleaved at the expected site by PR. Changes in can be used as both model substrates and inhibitors to the amino acids that flank the cleavage site ofthe peptide (and investigate the specificity and molecular parameters of the of the larger pol precursor) alter the capacity of the peptides reaction. The results indicate that a peptide that extends five to serve as substrates. Some peptides that are not cleaved act amino acids but not three amino acids in both directions from as inhibitors of PR. a known cleavage site is accurately hydrolyzed by the protease of avian sarcoma-leukosis virus. Substitutions of the amino MATERIALS AND METHODS acids to either side of the peptide bond to be cleaved affect the ability of the peptide (as well as a larger precursor protein) to PR Digestion of pol Precursor Proteins Synthesized in serve as a substrate.
    [Show full text]
  • 2019 Highlights
    Highlights of the Year Research Hundreds of scientists working in Cold Spring Harbor Laboratory’s 50-plus laboratory groups contributed to research that in 2019 was published in the world’s major research journals. Their efforts reflect the full spectrum of this institution’s scientific activity in cancer, neuroscience, plant biology, quantitative biology, and genomics. The following is a sampling of this year’s important findings. Machine Learning Better Interprets Gene Regulation Machine learning algorithms are helping biologists make sense of molecular signals that control how genes function, but algorithms developed to analyze larger and larger sets of data become increasingly complex and difficult to interpret. Associate Professor Justin B. Kinney has an approach to design advanced machine learning algorithms that are easier for biologists to understand. The algorithms are a type of artificial neural network (ANN). Inspired by the way neurons connect and branch in the brain, ANNs are the computational foundations for advanced machine learning. Biologists use ANNs to analyze data from an experimental method called a “massively parallel reporter assay” (MPRA), which investigates DNA. Using this data, quantitative biologists can make ANNs that predict which molecules J. Kinney control specific genes in a process called gene regulation. Unfortunately, the way standard ANNs are shaped from MPRA data is very different from how scientists ask questions in the life sciences. Kinney’s approach bridges this gap between computational tools and how biologists think. These custom ANNs mathematically reflect common concepts in biology concerning genes and the molecules that control them, forcing data to be processed in a way that a biologist can understand.
    [Show full text]
  • New Jersey Commission on Cancer Research
    New Jersey Commission on Cancer Research 2018-19 Annual Report Dedicated to conquering cancer through scientific research C2780 A Message from the Chair Dear Governor Murphy: r i s Chairperson of the New Jersey Commission on Cancer a Research and on behalf of our Commissioners, it gives me great pleasure to report on our activities over the past two h years for 2018 and 2019. A C In our 36-year history since the NJCCR was formed, by the NJ State Legislature, we have awarded more than $45 million for e over 900 peer reviewed cancer research grants and student fellowships. Our grantees have leveraged a return of over $10 in h federal research funding for every NJCCR dollar awarded for t over a total of $455 million. These grants have been awarded to the Cancer Institute of New Jersey, Rutgers University both in Newark and Piscataway, Princeton University, Rutgers School of Dental Medicine, Cooper Medical School at Rowan University m and to the Center for Discovery and Innovation at Hackensack o Medical Center. r These funds can be used for basic cancer science research, f including research for breast, lung, colon and prostate cancer. We have instituted our Annual Fall Cancer Research Symposium e where, for the past two years, we have had greater than 60 poster presentations by the grantees presenting their research findings. g At this event, we had a panel discussion on post-fellowship a employment opportunities by members of the New Jersey Commission on Cancer Research to help grantees find positions s after they have completed their research work.
    [Show full text]
  • The New Jersey Breast and Prostate Cancer Research Funds
    The New Jersey Commission on Cancer Research (NJCCR) promotes significant and original research in New Jersey into the causes, prevention and treatment of cancer and serves as a resource to providers and consumers of cancer services. Inside Message from the Chair.........................................................1 Our History and Approach...................................................3 NJCCR Members and Staff...................................................5 2005 - The Year’s Highlights................................................11 Research and Grant Highlights............................................17 Fellowships: A Commitment to the Future..........................21 Financial Summary.............................................................23 Advisory Group Members...................................................25 A Message from the Chair Dear Governor Corzine: On behalf of the State of New Jersey Commission on Cancer Research (NJCCR) we are pleased and proud to present our 2005 Annual Report. The NJCCR is a unique state agency which was formed in 1983 to launch a bold new attack on cancer. It has done this through the funding of research into the causes and treatment of cancer. This research has been conducted by promising young New Jersey scientists working in our academic institutions and hospitals. Through its system of peer review, utilizing the talents of some of our nation's leading scientists, we have funded over $27.6 million for 627 research projects on cancer over the past 20 years. However, this represents only a fraction of the total number of projects reviewed and approved, for which funding was not available. The NJCCR’s competitive seed grant program continues to gain national recognition as a model to effectively leverage major grants from national funding sources and has generated $5.65 in national research monies for every dollar awarded in seed grants (2004).
    [Show full text]
  • JOURNAL of VIROLOGY VOLUME 61 * DECEMBER 1987 * NUMBER 12 Arnold J
    JOURNAL OF VIROLOGY VOLUME 61 * DECEMBER 1987 * NUMBER 12 Arnold J. Levine, Editor in Chief Thomas E. Shenk, Editor (1989) (1989) Princeton University Princeton University Princeton, N.J. Princeton, N.J. Anna Marie Skalka, Editor (1989) Bernard N. Fields, Editor (1988) Fox Chase Cancer Center Harvard Medical School Philadelphia, Pa. Boston, Mass. George F. Vande Woude, Editor (1992) Robert A. Lamb, Editor (1992) NCI-Frederick Cancer Research Facility Northwestern University Frederick, Md. Evanston, Ill. Robert A. Weisberg, Editor (1988) Michael B. A. Oldstone, Editor (1988) National Institute of Child Health Scripps Clinic & Research Foundation and Human Development La Jolla, Calif. Bethesda, Md. EDITORIAL BOARD James Alwine (1988) Walter Gerhard (1989) Warren Masker (1987) Joseph Sambrook (1988) David Baltimore (1987) Joseph C. Glorioso (1989) Thomas Merigan (1989) Charles E. Samuel (1989) Tamar Ben-Porat (1987) Stephen P. Goff (1988) George Miller (1987) Priscilla A. Schaffer (1987) Kenneth I. Berns (1988) Larry M. Gold (1988) Lois K. Miller (1988) Sondra Schlesinger (1989) Michael Botchan (1989) Hidesaburo Hanafusa (1989) Peter Model (1989) Manfred Schubert (1988) Thomas J. Braciale (1988) John Hassell (1989) Bernard Moss (1989) Bart Sefton (1988) Joan Brugge (1988) William i. Hayward (1987) Opendra Narayan (1988) Bert L. Semler (1989) Michael J. Buchmeier (1989) Roger Hendrix (1987) Joseph R. Nevins (1988) Charles J. Sherr (1987) Barrie J. Carter (1987) John J. Holland (1987) Erling Norrby (1989) Saul J. Silverstein (1988) John M. Coffin (1989) Nancy Hopkins (1989) Nancy G. Nossal (1987) Patricia G. Spear (1987) Charles N. Cole (1989) Peter M. Howley (1987) Dennis O'Callaghan (1989) Bruce Stillman (1988) Geoffrey M.
    [Show full text]